Identification of G protein subunit alpha i3 as a promising oncotarget of LUAD

Gaomeng Luo1, Wenxuan Hu1, Jian Yang1

  • 1Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.

Cellular Signalling
|December 29, 2024
PubMed

Insights

Targeting G-protein alpha-i3 (Gαi3) inhibits lung adenocarcinoma (LUAD) growth. Gαi3 overexpression drives LUAD cell proliferation and migration, while its silencing promotes apoptosis and reduces tumor growth in vivo.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Lung adenocarcinoma (LUAD) cell growth requires identification of novel therapeutic targets.
  • G-protein alpha-i3 (Gαi3) is upregulated in LUAD and linked to poorer patient survival.

Purpose of the Study:

  • To investigate the role of Gαi3 in LUAD progression and evaluate its potential as a therapeutic target.

Main Methods:

  • Bioinformatical analysis of LUAD tissues.
  • Genetic manipulation of Gαi3 expression using shRNA and CRISPR/Cas9.
  • Assays for cell proliferation, migration, apoptosis, and mitochondrial membrane potential.
  • Western blotting and gene set enrichment analysis to explore signaling pathways.
  • In vivo xenograft models.

Main Results:

  • Gαi3 overexpression correlates with poor LUAD patient survival.
  • Gαi3 silencing or knockout inhibits LUAD cell proliferation, migration, and induces apoptosis.
  • Gαi3 regulates LUAD cell functions via the PI3K/Akt/mTOR pathway.
  • In vivo, Gαi3 downregulation via AAV-shRNA suppressed xenograft tumor growth.

Conclusions:

  • Gαi3 is a critical driver of LUAD progression.
  • Targeting Gαi3 represents a promising therapeutic strategy for lung adenocarcinoma.

Related Concept Videos

Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.9K